SavedAdd your journal

Journals / Fizyoterapi Rehabilitasyon / 2010 / Cilt: 21 - Sayı: 1

Serebral palsi ve nöromusküler hastalığı olan çocuklarda yaşam kalitesinin karşılaştırılması

A comparison of quality of life in children with cerebral palsy and neuromuscular diseases

Özgen ARAS
Ayşe KARADUMAN
Öznur YILMAZ
Bahar ARAS
Kerem Mintaze GÜNEL
Tülay TARSUSLU
Emine H. TÜZÜN
Akmel MUTLU
Pages
3–10
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: There were statistically significant differences between the groupsin the scores of the general health perceptions, parental impact-emotional and parental impact- time subscales of the CHQ-PF50 (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: This study aimed to compare health-related quality of life (HRQoL) between childrenwith cerebral palsy (CP) and neuromuscular diseases (NMD).
📊
Key Findings & Data:Material and methods: A total of 61children with CP and 50 children with NMD, ages ranged from 5-18 years participated in this study.Patients’ and parents’ characteristics were recorded.
💡
Conclusion & Impact:Results: There were statistically significant differences between the groupsin the scores of the general health perceptions, parental impact-emotional and parental impact- time subscales of the CHQ-PF50 (p
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: This study aimed to compare health-related quality of life (HRQoL) between childrenwith cerebral palsy (CP) and neuromuscular diseases (NMD). Material and methods: A total of 61children with CP and 50 children with NMD, ages ranged from 5-18 years participated in this study.Patients’ and parents’ characteristics were recorded. The HRQoL was assessed using the ChildHealth Questionnaire Parent Form 50 (CHQ-PF50). The children’s functional level was assessedusing Barthel Index. Results: There were statistically significant differences between the groupsin the scores of the general health perceptions, parental impact-emotional and parental impact- time subscales of the CHQ-PF50 (p

Özet

Amaç: Bu çalışma, nöromusküler hastalığı (NMH) olan çocuklar ile serebral palsili (SP) çocuklarınsağlıkla ilişkili yaşam kalitelerini (HRQoL) karşılaştırmak amacıyla planlandı. Gereç ve yöntem:Yaşları 5-18 yaş arasında değişen, 61 serebral palsili çocuk ve 50 NMH’li olan çocuk çalışmayaalındı. Olguların özellikleri kaydedildi. Yaşam kalitesi Çocuk Sağlık Anketi Aile Formu 50 (CHQ- PF50) kullanılarak değerlendirildi. Çocukların fonksiyonel seviyeleri Barthel İndeksi iledeğerlendirildi. Sonuçlar: Gruplar arasında, CHQ-PF50’nin alt skalaları olan genel sağlık algılaması,ailesel etki-emosyonel ve ailesel etki-zaman skorlarında anlamlı fark bulundu (p

🔖

Cite This Article

ARAS, Ö., KARADUMAN, A., YILMAZ, Ö., ARAS, B., GÜNEL, K. M., TARSUSLU, T., TÜZÜN, E. H., MUTLU, A. (2022). Serebral palsi ve nöromusküler hastalığı olan çocuklarda yaşam kalitesinin karşılaştırılması. Fizyoterapi Rehabilitasyon, Cilt: 21 - Sayı: 1, 3–10. https://ajindex.com/articles/516847

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Pharoah PO, Cooke T, Rosenbloom I, et al. Trends in birth prevalence of cerebral palsy. Arch Dis Child. 1987; 62: 379-384
  2. Boyle CA, Yeargin-Allsopp M, Doernberg NS, et al. Prevalence of selected developmental disabilities in children 3-10 years of age: the Metropolitan Atlanta Developmental Disabilities Surveillance Program 199l. MMWR CDC Surveill Summ. 1996;45:1-14
  3. Dubowitz W. The Muscular Dystrophies. In: Muscle Disorders in Childhood. Second Edition. WB Saunders Company. London; 1994:34-134
  4. Drougia A, Giapros V, Krallis N, et al. Incidence and risk factors for cerebral palsy in infants with perinatal problems: a 15-year review. Early Hum. Dev. 2007; 83: 541-547
  5. Tangsrud SE, Halvorsen S. Child neuromuscular disease in southern Norway. Prevalence, age and distribution of diagnosis with special reference to non-Duchenne muscular dystrophy. Clin Genet. 1988;34:145-152
  6. Ahlström G, Gunnarsson LG, Leissner P, et al. Epidemiology of neuromuscular diseases, including the postpolio sequelae, in a Swedish county. Neuroepidemiology. 1993;12:262-269
  7. Merlini L, Stagni SB, Marri E, et al. Epidemiology of neuromuscular disorders in the under-20 population in Bologna Province, Italy. Neuromuscul Disord. 1992;2:197-200
  8. Serdaroğlu A, Cansu A, Ozkan S, et al. Prevalence of cerebral palsy in Turkish children between the ages of 2 and 16 years. Dev Med Child Neurol. 2006;48:413-416
  9. Tunca O, Karaduman A, Aras O. Nöromusküler hastalıklarda fizyoterapi rehabilitasyonun aile ve çocuk üzerindeki etkileri. Fizyoter Rehabil. 1996;8:7-12
  10. Livingston MH, Rosenbaum PL, Russell DJ, et al. Quality of life among adolescents with cerebral palsy: what does the, literature tell us? Dev Med Child Neurol. 2007;49:225-231
  11. Piccininni M, Falsini C, Pizzi A. Quality of life in hereditary neuromuscular diseases. Acta Neurol Scand. 2004;109:113-119
  12. Uchikawa K, Liu M, Hanayama K, et al. Fuctional status and muscle strength in people with Duchenne muscular dystrophy living in the community. J Rehabil Med. 2004;36:124-129
  13. Colver A. SPARCLE group. Study protocol: SPARCLE- a multi-centre European study of the relationship of environment to participation and quality of life in children with cerebral palsy. BMC Public Health. 2006;6:105
  14. WHOQOL Assesment Group. Development and general psychometric properties. Soc Sci Med. 1998;46:1569-1855
  15. World Health Organization. Preamble to the Constitution of the World Health Organization. International H